-

China Biopharma, Clinical Development, CRO Utilization and Outlook Report 2023: Groundbreaking Insights into Clinical Development Trends, Activity, Budget Growth and Preferences - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023" report has been added to ResearchAndMarkets.com's offering.

This report takes a deep dive into the Chinese innovative biopharmaceutical market, providing groundbreaking insights into clinical development trends, activity, budget growth and preferences.

The report also details clinical development outsourcing preferences and practices to local and global Contract Research Organizations (CROs) and discusses the implications on future growth of the market. This highly strategic research should be considered foundational information for CROs, analysts and investors competing and following the evolving market.

The report examines perceptions of 101 professionals at domestic, Chinese innovative biopharmaceutical companies involved in clinical development and outsourcing to local and global Contract Research Organizations (CROs).

Topics covered include:

  • Clinical development trends and impact
  • Clinical development budget size and growth
  • Clinical trial composition by phase of development and outlook
  • Clinical development outsourcing practices by phase of development
  • CRO selection criteria and importance
  • Current clinical development outsourcing levels and growth outlook
  • CRO awareness and utilization
  • Unmet needs for clinical development services

Key Topics Covered:

I. Study Background

II. Key Conclusions and LSSG Discussion

III. Methodology

IV. Detailed Findings

  • Clinical Development Trends and Budget Size
  • Clinical Trial Characteristics by Phase and Geography
  • Clinical Development Outsourcing and Growth
  • Awareness and Utilization of Clinical Development Service Vendors Vendor Selection, Attributes and Importance
  • Unmet Needs

V. Respondent Demographics

VI. About the Publisher, LLC

Companies Mentioned

  • BOJIMed
  • CMIC
  • EPS
  • ICON/PRA
  • IQVIA
  • LabCorp/Covance
  • Leeway/Huawe Medicine
  • Medpace
  • Novotech
  • Parexel
  • Pharmaron
  • Syneos Health
  • Thermo Fisher/PPD
  • TigerMed
  • WuXi AppTec

For more information about this report visit https://www.researchandmarkets.com/r/adhsya

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom